Barbara Millwood

Learn More
PURPOSE S0205 was a randomized clinical trial that compared the therapeutic impact of gemcitabine versus gemcitabine plus cetuximab. Study results for patient-reported health-related quality of life (HRQL) outcomes are reported. PATIENTS AND METHODS Patients completed the Brief Pain Inventory and a measure of emotional well-being (each measured on a 0 to(More)
  • 1